Operaciones IRadimed Corporation - IRMD CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | - | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
IRadimed Corp ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Cierre previo* | N/A |
Abrir* | N/A |
Cambio de 1 año* | N/A |
Rango del día* | N/A |
Rango de 52 semanas | 25.23-49.30 |
Volumen medio (10 días) | 29.79K |
Volumen medio (3 meses) | 767.50K |
Capitalización de mercado | 610.72M |
Ratio P/E | 44.60 |
Acciones en circulación | 12.59M |
Ingresos | 56.47M |
EPS | 1.09 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.06 |
Próxima fecha de resultados | Jul 27, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|
IRadimed Corporation Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Friday, June 9, 2023 | ||
Hora (UTC) (UTC) 14:00 | País US
| Evento IRadimed Corp Annual Shareholders Meeting IRadimed Corp Annual Shareholders MeetingForecast -Previous - |
Thursday, June 15, 2023 | ||
Hora (UTC) (UTC) 14:00 | País US
| Evento IRadimed Corp Annual Shareholders Meeting IRadimed Corp Annual Shareholders MeetingForecast -Previous - |
Thursday, July 27, 2023 | ||
Hora (UTC) (UTC) 10:59 | País US
| Evento Q2 2023 IRadimed Corp Earnings Release Q2 2023 IRadimed Corp Earnings ReleaseForecast -Previous - |
Wednesday, November 1, 2023 | ||
Hora (UTC) (UTC) 12:30 | País US
| Evento Q3 2023 IRadimed Corp Earnings Release Q3 2023 IRadimed Corp Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 53.3032 | 41.8146 | 31.7174 | 38.5171 | 30.439 |
Ingresos | 53.3032 | 41.8146 | 31.7174 | 38.5171 | 30.439 |
Coste de los ingresos, total | 12.0207 | 9.76466 | 8.14296 | 8.81616 | 7.21163 |
Beneficio bruto | 41.2824 | 32.0499 | 23.5744 | 29.701 | 23.2274 |
Gastos totales de explotación | 37.6755 | 31.9969 | 32.4735 | 29.8697 | 24.4352 |
Gastos de venta/general/administración Gastos, total | 23.3767 | 20.3272 | 22.428 | 19.6209 | 15.7065 |
Investigación y desarrollo | 2.27808 | 1.90504 | 1.90253 | 1.43272 | 1.51711 |
Ingresos de explotación | 15.6277 | 9.81768 | -0.75609 | 8.6474 | 6.00377 |
Ingresos por intereses (gastos), netos No operativos | 0.5531 | 0.01861 | 0.13921 | 0.39591 | 0.19354 |
Otros, netos | |||||
Ingresos netos antes de impuestos | 16.1807 | 9.83629 | -0.61688 | 9.04332 | 6.19731 |
Ingresos netos después de impuestos | 12.8285 | 9.32547 | 0.569 | 9.63096 | 6.30345 |
Beneficio neto antes de partidas extra. Elementos | 12.8285 | 9.32547 | 0.569 | 9.63096 | 6.30345 |
Ingresos netos | 12.8285 | 9.32547 | 1.369 | 9.63096 | 6.30345 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 12.8285 | 9.32547 | 0.569 | 9.63096 | 6.30345 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 12.8285 | 9.32547 | 1.369 | 9.63096 | 6.30345 |
Beneficio neto diluido | 12.8285 | 9.32547 | 1.369 | 9.63096 | 6.30345 |
Promedio ponderado de acciones diluidas | 12.636 | 12.5908 | 12.4401 | 12.2764 | 12.1101 |
BPA diluido sin partidas extraordinarias | 1.01524 | 0.74065 | 0.04574 | 0.78451 | 0.52051 |
BPA normalizado diluido | 1.01524 | 0.74065 | 0.04574 | 0.78451 | 0.52051 |
Total de partidas extraordinarias | 0.8 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 15.4751 | 14.8636 | 13.4073 | 12.7216 | 12.3107 |
Ingresos | 15.4751 | 14.8636 | 13.4073 | 12.7216 | 12.3107 |
Coste de los ingresos, total | 3.75364 | 3.64322 | 2.86453 | 2.58181 | 2.93119 |
Beneficio bruto | 11.7214 | 11.2204 | 10.5427 | 10.1398 | 9.37952 |
Gastos totales de explotación | 11.4678 | 10.6097 | 9.27498 | 8.55499 | 9.23579 |
Gastos de venta/general/administración Gastos, total | 6.92049 | 6.36179 | 5.9188 | 5.31058 | 5.78551 |
Investigación y desarrollo | 0.79372 | 0.60474 | 0.49164 | 0.6626 | 0.5191 |
Ingresos de explotación | 4.00724 | 4.25384 | 4.13229 | 4.16658 | 3.07492 |
Otros, netos | 0.34241 | 0.44973 | 0.10518 | 0.0131 | -0.01492 |
Ingresos netos antes de impuestos | 4.34966 | 4.70358 | 4.23748 | 4.17968 | 3.06001 |
Ingresos netos después de impuestos | 3.40607 | 3.67362 | 3.4271 | 3.24105 | 2.48671 |
Beneficio neto antes de partidas extra. Elementos | 3.40607 | 3.67362 | 3.4271 | 3.24105 | 2.48671 |
Ingresos netos | 3.40607 | 3.67362 | 3.4271 | 3.24105 | 2.48671 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 3.40607 | 3.67362 | 3.4271 | 3.24105 | 2.48671 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 3.40607 | 3.67362 | 3.4271 | 3.24105 | 2.48671 |
Beneficio neto diluido | 3.40607 | 3.67362 | 3.4271 | 3.24105 | 2.48671 |
Promedio ponderado de acciones diluidas | 12.6867 | 12.6319 | 12.6311 | 12.6328 | 12.6555 |
BPA diluido sin partidas extraordinarias | 0.26848 | 0.29082 | 0.27132 | 0.25656 | 0.19649 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | 0.26848 | 0.29082 | 0.27132 | 0.25656 | 0.19649 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 77.4897 | 76.245 | 63.7359 | 58.9637 | 44.5417 |
Efectivo e inversiones a corto plazo | 57.9609 | 62.5014 | 51.9781 | 46.2501 | 34.3776 |
Efectivo y Equivalentes | 57.9609 | 61.9995 | 50.0687 | 43.4818 | 28.0277 |
Inversiones a corto plazo | 0 | 0.50186 | 1.90937 | 2.76829 | 6.34992 |
Total deudores, neto | 13.5286 | 8.44304 | 7.05214 | 8.66425 | 5.57788 |
Accounts Receivable - Trade, Net | 13.2745 | 5.1366 | 4.57493 | 7.2933 | 4.20999 |
Total Inventory | 5.36923 | 4.2998 | 3.93399 | 3.64156 | 4.05944 |
Prepaid Expenses | 0.63096 | 1.00072 | 0.77167 | 0.4078 | 0.52679 |
Total Assets | 85.5137 | 82.8814 | 71.0666 | 66.7289 | 48.4423 |
Property/Plant/Equipment, Total - Net | 4.6051 | 4.55146 | 4.83518 | 5.00968 | 1.86956 |
Property/Plant/Equipment, Total - Gross | 8.03543 | 7.41248 | 7.17159 | 6.86352 | 3.90101 |
Accumulated Depreciation, Total | -3.43033 | -2.86102 | -2.33641 | -1.85384 | -2.03145 |
Intangibles, Net | 2.06944 | 1.11858 | 0.96089 | 0.86009 | 0.83252 |
Other Long Term Assets, Total | 1.34954 | 0.96642 | 1.53467 | 1.89542 | 1.19846 |
Total Current Liabilities | 8.55374 | 6.82276 | 4.91726 | 5.85897 | 4.68952 |
Accounts Payable | 1.79932 | 0.7829 | 0.65705 | 0.99374 | 0.77247 |
Accrued Expenses | 3.28728 | 3.23144 | 2.07446 | 3.00363 | 1.93532 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 3.46715 | 2.80841 | 2.18575 | 1.8616 | 1.98173 |
Total Liabilities | 11.8408 | 10.7076 | 9.68201 | 11.2045 | 6.49653 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 3.28702 | 3.88486 | 4.76475 | 5.3455 | 1.80701 |
Total Equity | 73.673 | 72.1738 | 61.3846 | 55.5244 | 41.9457 |
Common Stock | 0.00126 | 0.00125 | 0.00123 | 0.00118 | 0.0011 |
Additional Paid-In Capital | 26.4074 | 25.1606 | 23.6768 | 19.1924 | 15.3173 |
Retained Earnings (Accumulated Deficit) | 47.2643 | 46.9949 | 37.6694 | 36.3004 | 26.6695 |
Other Equity, Total | 0 | 0.01701 | 0.03037 | -0.04219 | |
Total Liabilities & Shareholders’ Equity | 85.5137 | 82.8814 | 71.0666 | 66.7289 | 48.4423 |
Total Common Shares Outstanding | 12.591 | 12.544 | 12.3084 | 11.7659 | 10.9891 |
Unrealized Gain (Loss) | 0.03709 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 61.2984 | 77.4897 | 71.8733 | 68.495 | 65.5143 |
Efectivo e inversiones a corto plazo | 42.7772 | 57.9609 | 55.5922 | 52.1575 | 50.9466 |
Efectivo y Equivalentes | 42.7772 | 57.9609 | 55.5922 | 52.1575 | 50.4465 |
Inversiones a corto plazo | 0 | 0 | 0 | 0.50009 | |
Total deudores, neto | 11.5332 | 13.5286 | 10.6513 | 10.6778 | 9.2023 |
Accounts Receivable - Trade, Net | 11.5332 | 13.2745 | 10.6513 | 8.38224 | 6.51306 |
Total Inventory | 6.31227 | 5.36923 | 5.24326 | 4.85718 | 4.34504 |
Prepaid Expenses | 0.67575 | 0.63096 | 0.38663 | 0.80247 | 1.0204 |
Total Assets | 75.62 | 85.5137 | 79.5443 | 75.7238 | 72.3935 |
Property/Plant/Equipment, Total - Net | 10.9912 | 4.6051 | 4.56861 | 4.58149 | 4.56423 |
Property/Plant/Equipment, Total - Gross | 14.5788 | 8.03543 | 7.84959 | 7.71821 | 7.56011 |
Accumulated Depreciation, Total | -3.58764 | -3.43033 | -3.28099 | -3.13672 | -2.99589 |
Intangibles, Net | 2.20529 | 2.06944 | 1.88114 | 1.54313 | 1.33467 |
Other Long Term Assets, Total | 1.12516 | 1.34954 | 1.22129 | 1.10425 | 0.98029 |
Total Current Liabilities | 6.75612 | 8.55374 | 5.60363 | 6.1379 | 6.24924 |
Accounts Payable | 1.75618 | 1.79932 | 0.96436 | 0.82212 | 1.13665 |
Accrued Expenses | 2.08452 | 3.28728 | 2.8208 | 2.78943 | 2.28063 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.91543 | 3.46715 | 1.81847 | 2.52635 | 2.83195 |
Total Liabilities | 11.2801 | 11.8408 | 9.77306 | 9.8252 | 9.84506 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 4.524 | 3.28702 | 4.16944 | 3.6873 | 3.59583 |
Total Equity | 64.3399 | 73.673 | 69.7713 | 65.8986 | 62.5484 |
Common Stock | 0.00126 | 0.00126 | 0.00126 | 0.00126 | 0.00126 |
Additional Paid-In Capital | 26.8912 | 26.4074 | 26.1793 | 25.7338 | 25.6185 |
Retained Earnings (Accumulated Deficit) | 37.4474 | 47.2643 | 43.5907 | 40.1636 | 36.9225 |
Other Equity, Total | 0 | 0 | 0 | 0.00613 | |
Total Liabilities & Shareholders’ Equity | 75.62 | 85.5137 | 79.5443 | 75.7238 | 72.3935 |
Total Common Shares Outstanding | 12.5946 | 12.591 | 12.5653 | 12.561 | 12.5605 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | 12.8285 | 9.32547 | 1.369 | 9.63096 | 6.30345 |
Efectivo de actividades de explotación | 10.0427 | 11.2582 | 5.8175 | 10.2327 | 7.37602 |
Efectivo de actividades de explotación | 0.67067 | 1.40682 | 1.33882 | 1.24233 | 1.105 |
Deferred Taxes | 0.0571 | 0.52361 | 0.38993 | -0.59676 | -0.14443 |
Partidas no monetarias | 1.54284 | 1.57842 | 3.89195 | 1.92365 | 1.91998 |
Cash Taxes Paid | 1.7115 | 0.97 | 0 | 0.012 | 1.37571 |
Cambios en el capital circulante | -5.05639 | -1.57616 | -1.17221 | -1.96745 | -1.80799 |
Efectivo de actividades de inversión | -1.375 | 0.64824 | 0.24697 | 3.20119 | 1.51582 |
Gastos de capital | -1.875 | -0.74176 | -0.63675 | -0.48581 | -0.26467 |
Otras partidas de flujo de caja de inversión, total | 0.5 | 1.39 | 0.88372 | 3.687 | 1.78049 |
Efectivo procedente de actividades de financiación | -12.7064 | 0.02443 | 0.52248 | 2.02017 | 0.92987 |
Elementos de flujo de caja de financiación | -0.29398 | -0.59882 | -1.20762 | -0.47314 | -0.30956 |
Emisión (retiro) de acciones, neto | 0.14671 | 0.62324 | 1.7301 | 2.49332 | 1.23944 |
Variación neta de la tesorería | -4.03869 | 11.9308 | 6.58695 | 15.4541 | 9.82171 |
Total Cash Dividends Paid | -12.5591 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 3.40607 | 12.8285 | 9.15487 | 5.72777 | 2.48671 |
Cash From Operating Activities | 4.64609 | 10.0427 | 7.00387 | 3.06541 | 1.42619 |
Cash From Operating Activities | 0.18255 | 0.67067 | 1.36358 | 0.9281 | 0.43393 |
Deferred Taxes | 0.07866 | 0.0571 | -0.22713 | -0.14495 | -0.05204 |
Non-Cash Items | 0.80112 | 1.54284 | 1.04187 | 0.60264 | 0.46494 |
Cash Taxes Paid | 0 | 1.7115 | 0.75714 | 0.75714 | 0.00814 |
Changes in Working Capital | 0.1777 | -5.05639 | -4.32932 | -4.04815 | -1.90735 |
Cash From Investing Activities | -6.55701 | -1.375 | -0.90332 | -0.34713 | -0.42469 |
Capital Expenditures | -6.55701 | -1.875 | -1.40332 | -0.84713 | -0.42469 |
Cash From Financing Activities | -13.2728 | -12.7064 | -12.5079 | -12.5603 | -12.5546 |
Financing Cash Flow Items | -0.04988 | -0.29398 | -0.09552 | -0.07311 | -0.06738 |
Issuance (Retirement) of Stock, Net | 0 | 0.14671 | 0.14671 | 0.07195 | 0.07195 |
Net Change in Cash | -15.1837 | -4.03869 | -6.4074 | -9.84201 | -11.5531 |
Other Investing Cash Flow Items, Total | 0 | 0.5 | 0.5 | 0.5 | |
Total Cash Dividends Paid | -13.2229 | -12.5591 | -12.5591 | -12.5591 | -12.5591 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Susi (Roger E) | Individual Investor | 41.9058 | 5277950 | -120000 | 2023-03-31 | LOW |
Nine Ten Capital Management LLC | Investment Advisor/Hedge Fund | 6.2174 | 783066 | 1300 | 2023-03-31 | LOW |
Soleus Capital Management, L.P. | Hedge Fund | 6.143 | 773694 | 28690 | 2023-03-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 4.6099 | 580612 | -13700 | 2023-03-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.1394 | 395406 | 12535 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.0357 | 382338 | 7946 | 2023-03-31 | LOW |
RK Capital Management, LLC | Hedge Fund | 2.663 | 335400 | -30600 | 2023-03-31 | MED |
Bares Capital Management, Inc. | Investment Advisor | 2.5169 | 317000 | 45700 | 2023-03-31 | LOW |
Ranger Investment Management, L.P. | Investment Advisor | 1.6332 | 205692 | 7057 | 2023-03-31 | MED |
Russell Investments Trust Company | Investment Advisor | 1.4323 | 180394 | 8481 | 2023-03-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.4298 | 180076 | 14023 | 2023-03-31 | MED |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.4064 | 177138 | 16868 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.1219 | 141307 | 7396 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9868 | 124281 | 2870 | 2023-03-31 | LOW |
Hillsdale Investment Management Inc. | Investment Advisor/Hedge Fund | 0.8662 | 109100 | 600 | 2023-03-31 | MED |
Rice Hall James & Associates, LLC | Investment Advisor/Hedge Fund | 0.5738 | 72271 | -967 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.5174 | 65168 | 729 | 2023-03-31 | LOW |
Los Angeles Capital Management LLC | Investment Advisor/Hedge Fund | 0.4313 | 54320 | 41554 | 2023-03-31 | MED |
Citadel Advisors LLC | Hedge Fund | 0.4149 | 52260 | 37115 | 2023-03-31 | HIGH |
PanAgora Asset Management Inc. | Investment Advisor/Hedge Fund | 0.3685 | 46407 | 19379 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
IRadimed Corporation Company profile
Sobre Iradimed Corp
IRadimed Corporation desarrolla, fabrica, comercializa y distribuye dispositivos médicos y accesorios compatibles con la imagen por resonancia magnética (IRM) y servicios. Su sistema de bomba de infusión intravenosa MRidium 3860+ compatible con la IRM proporciona un sistema de bomba de infusión intravenosa (IV) no magnético que está específicamente diseñado para un uso seguro durante los procedimientos de IRM. Su sistema de bomba de infusión intravenosa compatible con RMN MRidium ha sido diseñado con un motor ultrasónico no magnético con piezas no ferrosas y otras características especiales para administrar anestesia de forma segura y predecible y otros medicamentos o fluidos intravenosos durante diversos procedimientos de RMN. Su sistema de monitorización de las constantes vitales del paciente IRadimed 3880 MRI Compatible ha sido diseñado con componentes no magnéticos y otras características para monitorizar las constantes vitales del paciente de forma segura y precisa durante varios procedimientos de resonancia magnética. La empresa vende sus productos principalmente a hospitales y centros de cuidados intensivos, tanto en Estados Unidos como en el extranjero.
El precio actual de la acción IRadimed Corporation en tiempo real es 0 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Shimao Property Holdings Limited, CSG Systems, EDREAMS ODIGEO, S.A., FORESIGHT SOLAR FUND LIMITED OR, Qiagen NV y FormFactor. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Medical Equipment |
1025 Willa Springs Dr.
WINTER SPRINGS
FLORIDA 32708
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com